Milestone Pharmaceuticals Inc (MIST)

NASDAQ
Currency in USD
1.565
-0.995(-38.88%)
Real-time Data·
MIST Scorecard
Full Analysis
Quickly burning through cash
Unusual trading volume
Fair Value
Day's Range
1.4601.930
52 wk Range
0.6252.750
Key Statistics
Edit
Prev. Close
2.56
Open
1.76
Day's Range
1.46-1.93
52 wk Range
0.625-2.75
Volume
18.91M
Average Vol. (3m)
1.05M
1-Year Change
76.19%
Book Value / Share
-0.09
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MIST Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
3.333
Upside
+112.99%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Milestone Pharmaceuticals Inc Company Profile

Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. The company’s lead product candidate is etripamil, a novel and potent calcium channel blocker, which has completed phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate. It has a license and collaboration agreement with Corxel Pharmaceuticals to develop and commercialize etripamil. Milestone Pharmaceuticals Inc.was incorporated in 2003 and is headquartered in Montreal, Canada.

Compare MIST to Peers and Sector

Metrics to compare
MIST
Peers
Sector
Relationship
P/E Ratio
−3.3x−0.7x−0.5x
PEG Ratio
−0.09−0.010.00
Price / Book
−27.8x0.8x2.6x
Price / LTM Sales
-1.7x3.1x
Upside (Analyst Target)
56.3%128.3%45.7%
Fair Value Upside
Unlock18.6%5.7%Unlock

Analyst Ratings

2 Buy
2 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 3.333
(+112.99% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.31 / -0.20
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MIST Income Statement

People Also Watch

5.320
BSGM
-9.22%
20.78
TSSI
-9.33%
68.39
PSIX
0.00%
9.49
PHAT
-2.06%
126.12
CRWV
-8.80%

FAQ

What Is the Milestone Pharmaceuticals (MIST) Stock Price Today?

The Milestone Pharmaceuticals stock price today is 1.57

What Stock Exchange Does Milestone Pharmaceuticals Trade On?

Milestone Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Milestone Pharmaceuticals?

The stock symbol for Milestone Pharmaceuticals is "MIST."

What Is the Milestone Pharmaceuticals Market Cap?

As of today, Milestone Pharmaceuticals market cap is 103.61M.

What Is Milestone Pharmaceuticals's Earnings Per Share (TTM)?

The Milestone Pharmaceuticals EPS (TTM) is -0.78.

When Is the Next Milestone Pharmaceuticals Earnings Date?

Milestone Pharmaceuticals will release its next earnings report on Aug 06, 2025.

From a Technical Analysis Perspective, Is MIST a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Milestone Pharmaceuticals Stock Split?

Milestone Pharmaceuticals has split 0 times.

How Many Employees Does Milestone Pharmaceuticals Have?

Milestone Pharmaceuticals has 33 employees.

What is the current trading status of Milestone Pharmaceuticals (MIST)?

As of Jul 11, 2025, Milestone Pharmaceuticals (MIST) is trading at a price of 1.57, with a previous close of 2.56. The stock has fluctuated within a day range of 1.46 to 1.93, while its 52-week range spans from 0.63 to 2.75.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.